Lower COVID Antibody Rates for Cancer Patients
Posted: May 29, 2020
Lower COVID Antibody Rates for Cancer Patients image

Cancer patients develop lower levels of antibodies against COVID-19 after having contracted the virus, according to a new paper in Annals of Oncology. French researchers at the Centre Léon Bérard in Lyon, France, showed that patients with cancer had significantly lower detection rates of SARS-COV2 antibodies 15 days or later after COVID-19 symptoms when compared to healthcare workers. 

Cancer patients were tested with a SARS-nCoV2 RT-OCR nasal swab test and a Toda Coronadiag rapid blood finger prick test 15 days after a positive PCR COVID test. 

  Cancer Patients (85 patients) Healthcare workers (244 patients)
COVID Positive (PCR test)

12% (10 pts)

6% (14 pts)
Detectable antibodies after 15 days

30% (3 of the 10 pts)

71% (10 of the 14 pts)


According to the researchers, additional studies will be necessary to confirm whether immune response to the virus is influenced by recent cancer treatments.

In multiple myeloma, we know that some vaccines have to be administered twice (like the flu vaccine) in a single season, or that booster shots might be important. Some patients also need IVIG infusions and have generally lower IgG or other immunoglobulin numbers because of the myeloma itself or because of the treatment. It's not surprising that cancer patient antibody levels would be lower than healthy heatlhcare workers. 


The author Jennifer Ahlstrom

about the author
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of Myeloma Crowd by HealthTree and the HealthTree Foundation.

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Legend Biotechnologies
Bristol Myers Squibb
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation for Multiple Myeloma (formerly know as Myeloma Crowd) is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811